• Home
  • Technology
    • Gelrin Technology and Status
    • Patents
    • Market, Competition and Opportunity
    • Videos
  • Investors
  • Contact Us
Regentis Biomaterials Logo
Regentis Biomaterials Logo
  • HOME
  • TECHNOLOGY
    • Gelrin Technology and Status
    • Patents
    • Market, Competition and Opportunity
    • Videos
  • INVESTORS
  • CONTACT US

Investor Relations

Annual Shareholder Meeting 2026

☰  IR MENU
  • Overview
  • News & Media
    • Press Releases
    • Media
  • SEC Filings
  • Stock Info
    • Stock Chart
    • Historical Stock Quote
    • Analyst Coverage
  • Events & Presentations
  • Governance
    • Scientific Advisory Board
    • Management
    • Board of Directors
    • Committee Composition
    • Documents
  • Resources
    • Contact IR
    • Email Alerts
  • Overview
  • News & Media
    • Press Releases
    • Media
  • SEC Filings
  • Stock Info
    • Stock Chart
    • Historical Stock Quote
    • Analyst Coverage
  • Events & Presentations
  • Governance
    • Scientific Advisory Board
    • Management
    • Board of Directors
    • Committee Composition
    • Documents
  • Resources
    • Contact IR
    • Email Alerts

Notice of an Annual General Meeting of the Shareholders to be Held on Thursday July 2, 2026

View Filing >

Proxy Statement for the Annual General Meeting of the Shareholders to be Held on Thursday July 2, 2026

View Filing >

Proxy for an Annual General Meeting of the Shareholders to be Held on Thursday July 2, 2026

View Filing >

20F for fiscal year ended on December 31, 2025

View Filing >

Security holders may request a hard copy of Regentis’s Annual Report, including its complete audited consolidated financial statements, free of charge, to its shareholders upon request to Regentis Investor Relations at 60 Medinat Hayehudim Street, 4676652, Israel or by phone at +972 (9) 960-1917. 

© 2026 Regentis Biomaterials. All Rights Reserved
|
Terms of Use
|
Privacy Policy
|
Accessibility Declaration
|
Sitemap
|
Powered by ACCESS Newswire
Share by: